The tribulations of stroke trials

Journal of NeuroInterventional Surgery

Volumn 5, Issue 3, 2013, Pages 181-183

  Albuquerque, Felipe C ^a   Fiorella, David ^b   Hirsch, Joshua A ^c   Prestigiacomo, Charles ^d   Tarr, Robert W ^e  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIFFUSION TENSOR IMAGING; DRUG MEGADOSE; EDITORIAL; EMBOLECTOMY; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANKIN SCALE; STUDY DESIGN; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; HUMANS; PROSPECTIVE STUDIES; STROKE;

EID: 84878391553     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010731     Document Type: Editorial

References (17)

1. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
2. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914-23.
3. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368:904-13.
4. Zaidat OO, Lazzaro MA, Gupta R, et al. Interventional management of stroke III trial: establishing the foundation. J Neurointerv Surg 2012;4:235-7.
5. Demchuk AM; IMS III Investigators. IMS III: comparison of outcomes between IV and IV/IA treatment in baseline CTA confirmed ICA, M1, M2 and basilar occlusions. International Stroke Conference; Honolulu, Hawaii, 2013.
6. Yoo AJ, Verduzco LA, Schaefer PW, et al. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefi t from early recanalization. Stroke 2009;40:2046-54.
7. Coutts SB, Lev MH, Eliasziw M, et al. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke 2004;35:2472-6. (Pubitemid 39458401)
8. Bhatia R, Bal SS, Shobha N, et al. Calgary CTA Group. CT angiographic source images predict outcome and final infarct volume better than noncontrast CT in proximal vascular occlusions. Stroke 2011;42:1575-80.
9. Zhu G, Michel P, Aghaebrahim A, et al. Computed tomography workup of patients suspected of acute ischemic stroke: perfusion computed tomography adds value compared with clinical evaluation, noncontrast computed tomography, and computed tomography angiogram in terms of predicting outcome. Stroke Published Online First: 12 Feb 2013. doi:10.1161/STROKEAHA.111.674705
10. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularization of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231-40.
11. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
12. Jahan R, Liebeskind D, Nogueira R, et al. for SWIFT Investigators. TICI success rates in swift: comparison between randomized arms and correlation to 90 day neurologic outcome. Stroke 2013;44:A163.
13. Khatri P, Abruzzo T, Yeatts SD, et al. IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72.
14. Zaidat OO, Lazzaro MA, Nogueira RG, et al. Time from symptoms onset to revascularization: impact on outcomes in revascularized swift trial patients. Stroke 2013; 44:ATP24.
15. The Penumbra Pivotal Trial Investigators. Penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8.
16. Tarr R, Hsu D, Kulcsar Z, et al. The POST trial: initial post-market experience of the Penumbral system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg 2010;2:341-4.
17. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.